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Chronic Bioassays of Chlorinated Humic
Acids in B6C3F1 Mice
by Benjamin L. Van Duuren,* Susan Melchionne,*
Irving Seidman,t and Michael A. Pereirat
Humic acids (Fluka), chlorinated to carbon:chlorine (C:Cl) ratios of 1:1 and 1:0.3, were administered
to B6C3F1 mice, 50 males and 50 females per group, in the drinking water at a total organic carbon (TOC)
level of 0.5 g/L. The mice were 6 to 8 weeks old at the beginning of the bioassays. The doses used were
based onshort-term (8weeks) evaluations fortoxicity, palatability, andweightgain. Thechronic bioassays
included the following control groups: unchlorinated humic acids (0.5 g/L), no-treatment (100 males and
100 females), dibromoethane (DBE, 2.0 mM in drinkingwater; positive control) and 0.44% sodium chloride
in drinking water, i.e., at the same concentration as those receiving chlorinated humic acids. The chlor-
inated humic acids were prepared freshly and chemically assayed once perweek. All chemicals were, with
the exception of DBE, administered for 24 months; DBE was administered for 18 months. The volumes
of solutions consumed were measured once weekly. All treatment groups showed normal weight gain
except the DBE group. At the completion of exposure, the animals were sacrificed and necropsied, and
tissue sections were taken for histopathology. No markedly significant increases in tumor incidences were
evident in any of the organs and tissues examined in the chlorinated humic acid groups compared to
unchlorinated humic acids and the no-treatment control groups. DBE caused the expected high incidence
of squamous carcinomas of the forestomach. The chlorinated humic acids tested contained direct-acting
alkylating agents, based on their reactivity with p-nitrobenzylpyridine (PNBP), and showed mutagenic
activity in S. typhimurium.
Introduction
The occurrence oflow molecular weight halogenated
aliphatic and olefinic hydrocarbons in the environment
and their potentially adverse human health effects has
become the subject ofintensive researchduringthepast
15 to 20 years. The upsurge ofresearch in this area was
spurred by the demonstration ofthe carcinogenic activ-
ity of vinyl chloride (1,2) and of other low molecular
weight, halogenated, saturated and unsaturated hydro-
carbons (3-6). These studies also focused on the chlo-
rination products of humic and fulvic acids of water as
sources of these compounds. This subject has been re-
cently reviewed (7). A substantial number of the com-
pounds formed during the chlorination of water con-
taining humic acids have been isolated, characterized,
and in some instances quantitated (8-13). The nature
and amounts ofthese by-products vary with the source
ofthe humic acids, which are a poorly defined group of
materials. Other factors that affect the nature of the
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products include pH, duration of chlorination, and ex-
tent of available analytical procedures brought to bear
on the problem. The nonvolatile, high molecular weight
products formed during the chlorination ofhumic acids
have recently received some attention as well (14).
The purpose of the present study was to determine
whether the mixture of chlorination products would
show carcinogenic activity in chronic bioassays in lab-
oratory animals when these substances were adminis-
tered in drinking water. For such experiments, where
high doses were required for chronic tests in animals,
itwas clearlyinfeasibletoconcentratehumicacids (HA)
from drinking water. A commercial source of humic
acid, therefore, was used. The validity of this decision
was confirmed in studies (15) before beginning the
chronic bioassay described here.
B6C3F1 mice were selected for the chronic bioassay
because of the considerable background information
available on these mice. They have been used exten-
sively in the carcinogenicity testing ofmany chemicals,
formerly under the auspices ofthe carcinogenesis test-
ing program of the National Cancer Institute and in
recent years as part of the National Toxicology Pro-
gram. The history, growth patterns, and lifespans (16),
as well as incidence ofspontaneous tumors (17), inthese
mice have been carefully documented. B6C3F1 mice
werealsousedrecentlyinthislaboratoryforthechronicVAN DUUREN ETAL.
bioassay of potential metabolites of the carcinogen di-
bromoethane administered in drinking water (18).
While the chronic bioassay described in this report
was underway, there were developments in other lab-
oratories concerning the mutagenicity of chlorinated
humic acids (11,14,15,19) and their possible initiating
activity in two-stage carcinogenesis in SENCAR mice
(15).
As part ofthe chronic bioassay described here, it was
essential to select chlorination conditions that were rea-
sonably close to actual chlorination conditions used to
disinfect water for human consumption. Also, it was
necessary to decide on concentrations of chlorinated
humic acids that resulted in acceptable palatability to
test animals, normal weight gains, and normal or close-
to-normal lifespans. In addition, chlorination conditions
had to be closely scrutinized to allow for sufficient sta-
bility ofproducts and test solutions compatible with the
protocols forthe chronic bioassay. The chronic bioassay
was preceded by short-term (8-week) assays of these
preparations.
As a part of the chronic bioassay, the alkylating ac-
tivity ofthe chlorinated humic acids was determined by
their reactivity with p-nitrobenzylpyridine (PNBP).
This assay was also used to determine the stability of
the chlorinated products during storage and use as test
solutions in drinking water. In addition, the mutagen-
icity of the chlorinated humic acids was determined in
S. typhimurium TA 98 and TA 100.
Methods
Animals
MaleandfemaleB6C3F1 mice (Harlan Sprague-Daw-
ley, Indianapolis, IN) were housed, six per stainless-
steel cage, on hardwood chips and fed Purina Rodent
Laboratory Chow. Males and females were housed in
separate animal rooms. Control groups, i.e., those re-
ceiving drinking water, sodium chloride, or unchlori-
nated humic acids, were housed in the same rooms as
those receiving chlorinated humic acids. The dibrom-
oethane (DBE) positive control groups were housed in
well-ventilated hoods having an air flow ofat least 100
linear ft/min. Animal housing areas were maintained at
22-240C.
Subchronic Bioassay
A short-term test of8 weeks duration was conducted
at three total organic carbon (TOC) levels (0.1, 0.2, and
0.5 g/L), all three at carbon:chlorine (C:Cl) ratios of 1:1
and 1:0.3. There were five mice per group for each of
these short-term tests. The three control groups, also
five mice per group, received drinking water only, so-
dium chloride (NaCl, 4.4 g/L), or unchlorinated humic
acids (TOC levels 0.1, 0.2, and 0.5 g/L). During the 6-
week treatment period, body weight and solution of
water intake were recorded once weekly. Treatment
was discontinued at the end of6weeks, and all animals
Table 1. Protocol for chronic bioassay of chlorinated humic
acids in B6C3F1 mice.
Fifty females and fifty males per group.
Test duration: 24 months
Test materials at 500 mg TOC/L
Unchlorinated humic acids
Chlorinated humic acids, C:Cl, 1:1
Chlorinated humic acids, C:Cl, 1:0.3
Control groups
Sodium chloride, 4.4 g/L
No treatmenta
Dibromoethane,b 2 mM = 0.375 g/L
Total mice: 700
a 100 animals/group.
bTest duration: 18 months.
were sacrificed and completely necropsied at the end of
8 weeks. Tissue sections from 12 organs were taken for
histopathology from one animal of each group. These
organs were: tongue, esophagus, stomach, (glandular-
and forestomach), duodenum, ileum, cecum, colon, rec-
tum, urinary bladder, kidney, lung, and liver. Organs
from all groups were clinically and microscopically nor-
mal. Body weight gain and fluid intake were normal for
all groups except for those receiving sodium chloride in
their drinking water, which showed a slight elevation
in fluid intake in both sexes.
Chronic Bioassay
Based on these short-term evaluations, the highest
TOC level, 0.5 g/L at C:Cl ratios 1:1 and 1:0.3, was
selected for the chronic bioassay. The humic and chlor-
inated humic acid solutions were prepared freshly once
per week as described below under chemicals. The de-
tailedprotocolsfortheselong-termbioassaysareshown
inTable 1. Solution and waterintakesandbodyweights
were recorded monthly. Animals were examined once
per week and palpated for the presence ofinternal le-
sions or any clinical signs of toxicity. Animals in mori-
bund condition were sacrificed by cervical dislocation.
Duringthe first 12 months ofthe chronic bioassay, very
few animals died. Tissue samples were taken at ne-
cropsy for histopathology ofthe following organs: lung,
stomach, liver, kidneys, urinarybladder, colon, rectum,
and gonads. During the second year of the test, the
number of tissues taken at necropsy was expanded to
include 26 tissues and organs as used in the National
ToxicologyProgram(20). Onesectionfromeachofthese
tissues was taken from each animal at death. All sam-
ples for histopathology were fixed in formalin, blocked,
cut, and stained with hematoxylin and eosin. Portions
oftissues not used for histopathology were also stored
in formalin in heat-sealed plastic bags for future ref-
erence ifneeded.
Preparation and Chemical Analysis of
Humic Acid and Chlorinated Humic Acid
Solutions
Onlythose aspects ofthe chemicalphases ofthework
pertaining to bioassays are givenhere. Detailed studies
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FIGURE 1. Dose response of unchlorinated humic acid (HA) and
freshly prepared chlorinated humic acids at C:Cl 1:1 and 1:0.3 in
S. typhimurium, TA 98 in the absence (-S9) and in the presence
(+S9) of microsomal activating system.
onfractionation bymolecularweightand otherchemical
studies will be reported elsewhere.
Humic acids (Fluka, Switzerland) wereusedthrough-
out this work. Stock solutions of humic acids for sub-
sequent chlorination were prepared as follows: a solu-
tion of humic acids, 5.0 g in 400 mL of 0.02 N sodium
hydroxide (NaOH), was stirred for 2 hr at room tem-
perature and the slightly acidic solution adjusted to pH
7.0 with 0.1 N NaOH. The solution was centrifuged at
2300 g for 90 min. The clear, dark-brown supernatant
solution was decanted, diluted to 1 L with distilled
water, and adjusted to pH 7.0. This solution was stored
overnight at 40C and filtered through Whatman glass
microfiber filters GF/D and 934-AH with particle re-
tentions of 2.7 and 1.5 ,um, respectively. Freeze-dried
aliquots ofthis humic acid stock solution were used for
various analyses including TOC analysis (TOC analyses
were performed at the Health Effects Research Lab-
oratories, U.S. Environmental Protection Agency
(EPA), Cincinnati, OH by using a Dohrmann organic
carbon analyzer). The TOC content ofthis solution was
2.0 g/L.
In a typical chlorination procedure, 250 mL of the
m 500
a.
0 400
1:1, + S9
> 300 _
a1)
200
- 1: ,/-.-3 - S 9
100 ~~~~~~~~HA
0 100 200 300 400 500
ILL of Sample Added
FIGURE 2. Dose response of unchlorinated humic acid (HA) and
freshly prepared chlorinated humic acids at C:Cl, 1:1 and 1:0.3 in
S. typhimurium, TA 100 in the absence (-S9) and in the presence
(+S9) of microsomal activating system.
humic acid stock solution in a 1-L amber container was
diluted to 475 mL with distilled water. The chlorine
content of a stock solution of sodium hypochlorite
(NaOCl; 4%-6%) wasdeterminedbyiodimetricanalysis.
The exact required volume of this stock solution was
diluted with distilled water, its pH adjusted to 7.0 with
6 N hydrochloric acid (HCl), and added to the humic
acid stock solution to attain C:Cl ratios of 1:1 and 1:0.3.
Table 2. Consumption of chemical solutions and survival in
male mice.
Average amount/ Number of
mouse/day survivors
Treatment mL mg 12 Months 24 Months
Unchlorinated humic 5.5 2.8 (TOC) 50 45
acid (HA)
Chlorinated HA
C:Cl, 1:1 5.5 2.8 (TOC) 49 42
C:Cl, 1:0.3 5.7 2.9 (TOC) 50 39
Sodium chloride 6.0 26.4 49 45
Dibromoethane 3.6 1.4 48 34a
No treatmentb 5.7 99 78
aTerminated at 18 months.
b 100 mice, other groups, 50 mice.
a)
a)
0l.
(I)
a)
at)
I HA, -S91
ill
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Table 3. Consumption of chemical solutions and survival in
female mice.
Average amount/ Number of
mouse/day survivors
Treatment mL mg 12 Months 24 Months
Unchlorinated humic 4.2 2.1 (TOC) 49 48
acid (HA)
Chlorinated HA
C:Cl, 1:1 4.4 2.2 (TOC) 50 43
C:Cl, 1:0.3 4.3 2.2 (TOC) 50 41
Sodium chloride 5.0 22.0 48 44
Dibromoethane 3.3 1.2 50 39a
No treatmentb 4.4 - 99 91
aTerminated at 18 months.
b 100 mice; other groups, 50 mice.
The 1-liter container was filled with distilled water,
leaving no head space, stoppered, and stored at room
temperature for6days. Afterreaction, thefreeresidual
chlorine content, as determined by iodimetric titration,
was less than 10 mg/L. The final pH ofthe chlorinated
solutions was in the range of 2.2 to 3.3. All solutions
for bioassay were adjusted to pH 5.0 with 1 N NaOH
and stored at 4°C. The chlorinated humic acid solutions
for bioassay were prepared freshly once per week and
were assayed forTOC andtotal organic halogen (TOX).
Both TOC and TOX analyses were performed by the
Health Effects Research Laboratory, U.S. EPA, Cin-
cinnati, OH. These samples were also analyzed for mu-
tagenicity (21) and alkylating activity (22).
Reactivity of Chlorinated Humic Acids
with PNBP
The chlorinated humic acids were analyzed for alkyl-
atingactivityin stocksolutions and inbioassaysolutions
using the PNBP method, a widely used, but still semi-
quantitative procedure (22). It depends on the devel-
opment of an unstable, colored reaction mixture after
reaction of alkylating agents with PNBP and addition
of base. A known alkylating agent, bromoacetic acid
(BrCH2COOH), was used as standard. This compound
does not absorb light in the ultraviolet-visible region
and is very soluble in water, the medium of choice for
the present work. A standard curve was constructed
by using 5.0 to 50.0 mg/L ofBrCH2COOH in the pres-
Table 4. Average body weights for male and female mice.
Average body
weight, g Range, g
Treatment Males Females Males Females
Unchlorinated
humic acid (HA) 34 27 21-38 16-32
Chlorinated HA
C:Cl, 1:1 33 28 19-36 17-32
C:Cl, 1:0.3 34 27 20-37 17-33
Sodium chloride 35 28 22-39 16-33
Dibromoethane 28 23 15-31 14-26
No treatment 35 27 20-38 16-32
Table 5. Tumor incidences with chlorinated humic acids (TOC,
500 mg/L; C:Cl 1:1).
Site Number Type
Females (49 necropsied)
Skin 2 Hemangioma
10 Sarcoma
Lung 5 Papillary tumor
Lymph node 5 Hemangioma (p < 0.005)
Spleen 2 Hemangioma
Blood vessel 1 Hemangioma
Liver 3 Hemangioma
1 Hyperplastic nodule
Stomach 6 Papilloma (forestomach)
1 Squamous carcinoma
(forestomach)
Perianal gland 1 Adenoma
Uterus/uterine horns 1 Leiomyoma
Ovaries/oviducts 3 Hemangioma (p 0.05)
Mammary gland 2 Mammary tumor
2 Carcinoma
Harderian/lacrimal gland 5 Papillary adenoma (p 0.05)
Mice with tumor 42a
Mice with leukemia 35
Males (49 necropsied)
Skin 1 Papilloma
15 Sarcoma
Lung 16 Papillary tumor
Lymph node 2 Hemangioma
Liver 5 Hemangioma
11 Hyperplastic nodule
2 Hepatoma
Stomach 1 Papilloma (forestomach)
Duodenum 1 Adenocarcinoma
Anus 1 Adenomallow-grade
adenocarcinoma
Preputial gland 1 Adenoma
Harderian/lacrimal gland 4 Papillary adenoma
Mice with tumor 44b
Mice with leukemia 29
830 with solid tumor.
b34 with solid tumor.
ence of an excess of PNBP. The blue color was devel-
oped by adding triethylamine, and absorbance at 570
nm was measured. The same procedure was applied to
aliquots of the chlorinated humic acids from various
chlorination conditions, C:Cl ratios from 1:0.3 to 1:1.2,
before and afterfreeze-drying, at various pH levels and
duration ofstorage. All solutions assayed, includingthe
reaction blanks BrCH2COOH, PNBP, and unchlori-
nated and chlorinated humic acids, were run in tripli-
cate.
Mutagenicity of Chlorinated Humic Acids
using S. typhimurium
Four tester strains, TA 98, TA 100, TA 1537 and TA
1538 were used in exploratory studies in the presence
and absence of an S-9 liver microsomal activating sys-
tem (21). TA 1537 and TA 1538 were less sensitive than
TA 98 and TA 100 and hence were not used in further
work. Allbacterialtoxicity andmutagenicity assays de-
scribed in this report were carried out by Litton Bio-
netics, Inc. (Kensington, MD). Unchlorinated and
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Table 6. Tumor incidences with chlorinated humic acids (TOC,
500 mg/L; C:CI, 1:0.3).
Site Number Type
Females (50 necropsied)
Skin 6 Sarcoma
Lung 4 Papillary tumor
Lymph node 2 Hemangioma (p -0.05)
Spleen 1 Hemangioma
Liver 1 Hepatoma
1 Hemangioma
2 Hyperplastic nodule
Stomach 3 Papilloma (forestomach)
Duodenum 1 Adenoma
Adrenal gland 1 Undifferentiated malignant
tumor
Uterus/uterine horns 1 Papillary adenoma
2 Hemangioma
Mammary gland 2 Mammary tumor
2 Carcinoma
Brain 2 Hemangioma (p < 0.05)
Harderian/lacrimal gland 3 Papillary adenoma
Ear duct gland 1 Carcinoma
Skeletal system 1 Osteoma
Mice with tumor 44a
Mice with leukemia 32
Males (50 necropsied)
Skin 1 Papilloma
1 Squamous carcinoma
2 Fibroma
15 Sarcoma
Lung 17 Papillary tumor
Lymph node 2 Hemangioma
Liver 3 Hemangioma
10 Hyperplastic nodule
3 Hepatoma
Stomach 1 Papilloma (forestomach)
1 Adenocarcinoma
(glandular stomach)
Testes 1 Leydig cell tumor
Preputial gland 1 Adenoma
Prostate gland 2 Adenocarcinoma (p < 0.05)
Harderian/lacrimal gland 2 Papillary adenoma
Skeletal system 2 Osteoma (p < 0.05)
Mice with tumor 43b
Mice with leukemia 17
'26 with solid tumor.
b36 with solid tumor.
chlorinated humic acids (C:Cl, 1:1 and 1:0.3) weretested
as fresh solutions and as freeze-dried and reconstituted
solutions in distilled water at three times their original
concentrations. Four dose levels, two plates per dose,
with and without S9 activation were assayed. Sodium
azide (for TA 100) and 2-nitrofluorene (for TA 98) with-
out S9 activation were used as positive controls; 2-ami-
noanthracene was used as the positive control for both
tester strains in the presence of S9 (19).
Results
Total Organic Halogen Content
TOX analyses wereperformed onsixtoeight samples
for each of the 2 chlorinated humic acids. At C:Cl 1:1
and 1:0.3, the average TOX analyses were 222 and 69.3
mg/L, respectively.
Table 7. Tumor incidences with unchlorinated humic acids
(TOC, 500 mg/L).
Site Number Type
Females (48 necropsied)
Skin
Lung
Lymph node
Spleen
Liver
Stomach
Duodenum
Jejunum/ileum
Thyroid gland
Mammary gland
Mice with tumor
Mice with leukemia
Males (50 necropsied)
Skin
Lung
Spleen
Lymph node
Liver
Stomach
Duodenum
Jejunum/ileum
Kidney
Testes
Mammary gland
Harderian/lacrimal gland
Mice with tumor
Mice with leukemia
a26 with solid tumor.
b39 with solid tumor.
1 Papilloma
9 Sarcoma
7 Papillary tumor
2 Hemangioma (p 0.05)
1 Hemangioma
4 Hemangioma
2 Hyperplastic nodule
1 Papilloma (forestomach)
1 Squamous carcinoma
(forestomach)
1 Adenoma
1 Adenocarcinoma
1 Poorly differentiated
carcinoma
1 Adenoma
3 Mammary tumor 44a
41
19 Sarcoma
1 Spindle cell tumor (benign)
17 Papillary tumor
2 Hemangioma
3 Hemangioma
3 Hemangioma
3 Hyperplastic nodule
7 Hepatoma
1 Papilloma (forestomach)
1 Adenoma (glandular
stomach)
1 Adenocarcinoma (glandular
stomach)
1 Neuroendocrine tumor
(glandular stomach)
1 Adenoma
1 Focal atypical hyperplasia/
carcinoma in situ
1 Adenocarcinoma
1 Cortical adenoma
1 Interstitial cell tumor
1 Adenocarcinoma
4 Papillary adenoma
42b
16
Alkylating Activity and Mutagenicity
Humic acids chlorinated at C:Cl 1:0.3 and unchlori-
nated starting material did not show any activity in the
PNBP assay. Chlorinated humic acids at C:Cl 1:1
showed notable absorption in this assay at 570 nm. For
all three samples the TOC concentration was 1.0 g/L;
chlorinated humic acids, C:CI 1:1, showed alkylating
activityof> 80ppm(equivalence ofBrCH2COOH). The
effects of freeze-drying, pH, and storage on the alkyl-
ating activity of chlorinated humic acids are described
elsewhere (23).
The results of the mutagenicity assays using the
tester strains TA 98 and TA 100 are shown in Figures
1 and 2. The positive controls (not shown) gave the
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Table 8. Tumor incidences in NaCI (4.4 g/L) control groups.
Site Number Type
Females (47 necropsied)
Skin 1 Papilloma
9 Sarcoma
Lung 11 Papillary tumor
Lymph node 1 Hemangioma
Spleen 1 Hemangioma
Liver 1 Hyperplastic nodule
Stomach 2 Papilloma (forestomach)
1 Papilloma with focal
carcinoma (forestomach)
Jejunum/ileum 1 Sarcoma
Uterus/uterine horns 2 Leiomyoma
1 Hemangioma
2 Sarcoma
Ovaries/oviducts 1 Hilar cell adenoma
1 Benign cystic tumor
Vagina 1 Squamous carcinoma
Mammary gland 3 Mammary tumor
1 Hemangioma
Harderian/lacrimal gland 3 Papillary adenoma
Adipose tissue 1 Hemangioma
Mice with tumor 40a
Mice with leukemia 30
Males (50 necropsied)
Skin 9 Sarcoma
Lung 16 Papillary tumor
Spleen 1 Hemangioma
Lymph node 1 Hemangioma
Liver 4 Hemangioma
11 Hyperplastic nodule
6 Hepatoma
Stomach 1 Papilloma (forestomach)
Harderian/lacrimal gland 3 Papillary adenoma
Mice with tumor 43b
Mice with leukemia 20
'27 with solid tumor.
b35 with solid tumor.
Table 9. Tumor incidences in untreated control groups (100
females and 100 males).
Site
Females (96 necropsied)
Skin
Lung
Spleen
Liver
Stomach
Caecum
Thyroid gland
Uterus/uterine horns
Ovaries/oviducts
Clitoral gland
Mammary gland
Harderian/lacrimal gland
Mice with tumor
Mice with leukemia
Males (99 necropsied)
Skin
Lung
Spleen
Lymph node
Heart
Blood vessels
Liver
Stomach
expected results (19). Both chlorinated humic acids
(C:C1, 1:1 and 1:0.3) showed highest activity in the ab-
sence of the S9 activating system and showed a clear
dose-response pattern under the experimental condi-
tions used. The unchlorinated material did not show
significant activity compared to controls, and the rev-
ertants per plate were markedly higher at C:C1 1:1,
compared to C:C1 1:0.3. At both C:C1 ratios, thefreshly
chlorinated preparations showed more than four times
the activity in both tester strains in the absence ofS9,
compared to freeze-dried material tested under the
same conditions (23). The mutagenic activity in both
tester strains for both ratios ofchlorinated humic acids
4days afterpreparation anduse onanimalcagesranged
from 52 to 69% compared to freshly prepared solutions
in the absence ofthe S9 system.
Chronic Bioassay
The consumption of chemical solutions and survival
in male and female mice in the chronic bioassays are
shown in Tables 2 and 3, respectively. In both sexes,
the consumption of solutions for unchlorinated and
chlorinated humic acids was the same as that in un-
Jejunum/ileum
Preputial gland
Mammary gland
Harderian/lacrimal gland
Mice with tumor
Mice with leukemia
a57 with solid tumor.
b67 with solid tumor.
Number Type
1
19
1
13
3
2
3
2
9
1
1
1
4
1
1
1
1
4
2
3
84a
63
Papilloma
Sarcoma
Hemangioma
Papillary tumor
Hemangioma
Hepatoma
Hemangioma
Hyperplastic nodule
Papilloma (forestomach)
Adenoma
(glandular stomach)
Leiomyoma
Papillary carcinoma
Hemangioma
Papilloma
Leiomyoma
Hemangioma
Adenoma
Mammary tumor
Carcinoma
Papillary adenoma
1 Papilloma
1 Squamous carcinoma
26 Sarcoma
22 Papillary tumor
4 Hemangioma
4 Hemangioma
1 Sarcoma
1 Hemangioma
3 Hemangioma
15 Hyperplastic nodule
12 Hepatoma
5 Papilloma (forestomach)
2 Squamous carcinoma
(forestomach)
1 Atypical hyperplasia
(early carcinoma)
1 Adenoma
1 Hemangiosarcoma
1 Mammary tumor
4 Papillary adenoma
76b
23
treated control groups; intake ofDBE solution was de-
pressed and of NaCl solution increased. Survival for
test groups, except DBE, was the same as that for
control groups.
The average body weights and body weight ranges
for both sexes are shown in Table 4. The animals ex-
posed to chemicals in the drinkingwater, exceptforthe
DBE group, gave the same body weight versus days-
on-test curves, and, hence, the results are shown only
in summary formn in Table 4.
The complete pathologic findings concerning benign
and malignant tumors for all test and control animals
are tabulated in Table 5 through 10. The significance
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Table 10. Tumor incidences in dibromoethane (2 mM) positive
control group.
Site Number Type
Females (49 necropsied)
Skin 1 Malignant tumor
Lung 2 Papillary tumor
Thymus 1 Malignant tumor
Spleen 1 Hemangioma
Tongue 1 Squamous carcinoma in situ
Esophagus 4 Papilloma
Liver 1 Hyperplastic nodule
Stomach 29 Papilloma (forestomach)
(p < 0.0005)
20 Squamous carcinoma
(forestomach) (p < 0.0005)
Mammary gland 1 Mammary tumor
1 Carcinoma
Harderian/lacrimal gland 2 Papillary adenoma
Mice with tumors 49a
Mice with leukemia 5
Males (48 necropsied)
Esophagus 4 Papilloma (p < 0.01)
4 Squamous carcinoma
(p < 0.01)
Liver 1 Hyperplastic nodule
1 Hepatoma
Stomach 6 Papilloma (forestomach)
41 Squamous carcinoma
(forestomach) (p < 0.0005)
Caecum 1 Carcinoma
Mice with tumor 48b
Mice with leukemia 1
a49 with solid tumor.
b48 with solid tumor.
values given in these tables were calculated by the chi-
square method used in our earlier work (18). Metastatic
tumors that occurred are not listed in Tables 5-10.
Discussion
An examination of the literature on the products
formed during the chlorination of water and of humic
and fulvic acids reveals that only a few of them have
been examined for possible deleterious health effects in
humans. Undue emphasis has been placed on halogen-
ated methanes, particularly chloroform, because of its
carcinogenic activity in rodents. High molecular weight
and nonvolatile chlorinated humic acids constitute the
major part ofthe chlorination products ofhumic acids,
yet their chemical structures are unknown and their
biological properties have only recently received atten-
tion (14). Other chlorination products ofdrinking water
sources and of humic acids (11-13) include chlorocar-
boxylic acids, chlorophenols, chloroketones, and chlo-
roacetonitriles. The potential mutagenicity and/or car-
cinogenicity of afew ofthese components have received
attention (6).
Based on the above information, we decided to per-
form chronic animal bioassays, not on individual com-
ponents of drinking water, but rather on the mixture
of products itself, since this is what is consumed daily
by humans. Such a mixture of products undoubtedly
contains not only small amounts ofcarcinogens, but also
cocarcinogens and, not to be disregarded, tumor-inhib-
itory agents. The importance of cocarcinogens (24,25)
and of tumor-inhibitory agents (26) in environmental
chemical carcinogenesis has been reviewed.
Although concentrates ofhumic acids and their chlo-
rination products can conceivably be prepared directly
from drinking water sources, this approach is undesir-
able for chronic bioassays in laboratory animals for sev-
eral reasons. Itisimpractical to preparethesematerials
in sufficiently high concentrations forbioassays at max-
imum tolerated doses. Equally important is that, in
spite of all attempts to avoid loss and degradation of
some products of chlorination, e.g., volatile or highly
reactivechemicals, these processesundoubtedlywill oc-
curduringconcentration. Impuritiesinorganicsolvents
used for extraction ofchlorination products from drink-
ing water and incomplete extraction involved in these
procedures only serve to compound the difficulties en-
countered in this approach to developing a source of
concentrated mixtures of chlorinated humic acid prod-
ucts for chronic animal bioassays.
Fluka humic acid as well as humic/fulvic acid prepa-
rations from water sources have been used to examine
chlorination products of drinking water, and this ap-
proach has been invaluable for isolating and character-
izing many drinking water chemicals and for establish-
ing the mutagenic activity ofthese materials and some
oftheirfractions inbacterialsystems (8-15). These con-
siderations led to the selection of Fluka humic acid for
the bioassays described in this report.
The chlorination products showed mutagenic activity
in S. typhimurium tester strains TA 98 and TA 100.
Table 11. Summary of tumor incidences (benign and malignant) in bioassays of chlorinated humic acids.
Mice with leukemia, % Solid tumor, % Mice with tumor, %
Treatment Females Males Females Males Females Males
Chlorinated humic
acids (HACI), 1:1 70 58 60 68 84 88
HACI, 1:0.3 64 34 52 72 88 86
HA 82 32 52 78 88 84
NaCl 60 40 54 70 180 86
No treatment 63 23 57 67 84 76
DBE 10 2 98 96 98 96
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Table 12. Summary of significant tumor incidences in bioassay
of chlorinated humic acids.a
Tumor
Treatment Females Males
HAC1, 1:1 Lymph node, None
5 hemangioma
(p < 0.005)
Ovaries/oviducts,
3 hemangioma
(p 0.05)
Harderian/lacrimal
gland, 5 papillary
adenoma, p -0.05
HAC1, 1:0.3 Lymph node, Prostate gland,
2 hemangioma 2 adenocarcinoma
(p 0.05) (p <0.05)
Brain, 2 hemangioma Skeletal system,
(p < 0.05) 2 osteoma
(p < 0.05)
HA Lymph node, None
2 hemangioma
(p 0.05)
aSignificance compared with untreated controls. It should be noted
that none of the above tumor incidences was significantly different
from the NaCl control groups.
In agreement with earlier observations (19), this mu-
tagenic activity was found to be greater in the absence
of an S9 liver microsomal activating system than in its
presence. Thus, most of the chemicals responsible for
thismutagenic activityare direct-actingmutagens. This
observation, when combined with the observed alkyl-
ating activity of chlorinated humic acids, is important
with regard to the possible carcinogenicity of chlori-
nation products in rodent bioassays. We also examined
theincrease inalkylatingactivityandmutagenicitywith
increasing TOX levels. At the lower C:Cl ratio, 1:0.3,
alkylating activity was not observed by the PNBP
method, which we ascribe to inadequate sensitivity of
this method. Mutagenic activity, as determined in this
work, was also found to persist in chlorinated humic
acids after fractionation by molecular weight and after
freeze-drying (23).
For the purposes of discussion, the total tumor inci-
dences in the chronic bioassay reported here are given
in Table 11 as a percentage of animals tested with tu-
mors (benign and malignant). The positive control,
DBE, resulted inthe expected highincidenceofanimals
with tumors (18), which supports the contention that
these animals are suitable for chronic bioassay ofhumic
acids. The only notable observation regarding tumor
incidences in the test groups compared to controls was
anincreased incidence ofleukemia inmales inthe chlor-
inated humic acid 1:1 group, which was more than dou-
ble the incidence in the no-treatment controls but not
significantly different from that of the NaCl controls.
No other pattern of tumorigenicity emerged from an
examination ofthe tumorincidences presented in Table
11. A fewmarginally significant (p 0.05) to significant
(p < 0.05 to p < 0.005) incidences of solid tumors oc-
curred, and these are listed in Table 12. Administration
of chlorinated humic acid, 1:0.3, to male mice resulted
in animals with adenocarcinoma of the prostate gland
and two with osteoma. Significant incidences oftumors
were not observed in males exposed to the higher level
of chlorinated humic acid, 1:1. Hemangiomas of the
lymph nodes were observed in females exposed to both
levels of chlorinated humic acids, unchlorinated humic
acid, and NaCl, and hence chlorination of humic acids
does not account for this low incidence ofhemangiomas
in females.
A recently published report (27), described the use
ofaconcentrate ofmutagenicorganicsindrinkingwater
forchronic bioassayinmale andfemaleWistarrats. The
incidence of tumors in these animals did not differ sig-
nificantly from those in untreated control groups. The
authors pointed out that the absence of tumorigenic
response may be attributable to the low levels of mu-
tagenic organics administeredtotheanimalsindrinking
water.
In summary, chlorinated humic acids administered to
both sexes ofa widely used strain ofmice in acceptable
group sizes and at high dose levels resulted in only a
few animals with significant numbers of tumors that
were not related to the chlorination of humic acids.
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